{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:38:22Z","timestamp":1793860702594,"version":"4.6.1"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To evaluate the effects of vitamin D on the endocrine, metabolic, and inflammatory markers providing new PCOS treatment ideas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed, EMBASE, Web of Science, and Cochrane Library were systematically searched for vitamin D treatment studies in PCOS patients from establishment to 12\/2022 using vitamin D, polycystic ovary syndrome, PCOS, etc, as search terms. Two researchers independently screened the retrieved literature, extracted the data, and finally performed a meta-analysis of these data with Review Manager 5.4 software to calculate all-parameter weighted mean difference (WMDs) and 95% confidence intervals (CIs) using a fixed-effects or random-effect models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The 10 included articles mainly studied the effects of vitamin D and placebo control treatment on endocrine, metabolic and inflammatory indicators in PCOS patients. Meta-analysis results showed that compared to placebo, vitamin D reduces the homeostatic model assessment-insulin resistance index (HOMA-IR) (MD\u2005=\u2005\u22120.47; 95% CI: \u22120.66 to \u22120.28;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), fasting serum insulin (FBI) (MD\u2005=\u2005\u22121.25; 95% CI: \u22122.44 to \u22120.06;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.04), hypersensitive C-reactive protein (hs-CRP) (MD\u2005=\u2005\u22121.18; 95% CI: \u22122.13 to \u22120.24;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.01) and total testosterone (TT) (MD\u2005=\u2005\u22120.33; 95% CI: \u22120.58 to \u22120.08;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.009) level. However, there were no significant differences in the other endocrine or metabolic indicators (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Current evidence indicates that vitamin D supplementation significantly reduced the HOMA-IR, hs-CRP, FBI, and TT in PCOS patients. However, fasting blood glucose (FPG), dehydroepiandrosterone sulfate (DHEAS), free androgen index (FAI), sex hormone-binding globulin (SHBG), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were unaffected.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046892","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:03:01Z","timestamp":1767711781000},"page":"e46892","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["A meta-analysis of the effects of vitamin D supplementation on endocrine metabolic and inflammatory markers in patients with polycystic ovarian syndrome"],"prefix":"10.1097","volume":"105","author":[{"given":"Baohua","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Shenzhen Amcare Maternity Hospital, LiuZhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medical Center, the Affiliated Hospital of Guilin Medical University, Guilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260218","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jama.2021.23769","article-title":"Diagnosis and treatment of polycystic ovary syndrome.","volume":"327","author":"Huddleston","year":"2022","journal-title":"JAMA"},{"key":"R2-20260218","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.","volume":"89","author":"Teede","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R3-20260218","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome.","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R4-20260218","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11154-021-09693-7","article-title":"Vitamin D: dosing, levels, form, and route of administration: does one approach fit all?","volume":"22","author":"Bilezikian","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"R5-20260218","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.3390\/ijms21186573","article-title":"An update on vitamin D metabolism.","volume":"21","author":"Saponaro","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R6-20260218","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications.","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem Biol"},{"key":"R7-20260218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590.2019.1625881","article-title":"Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.","volume":"36","author":"Menichini","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R8-20260218","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/nu14081649","article-title":"Effects of vitamin D on fertility, pregnancy and polycystic ovary syndrome \u2013 a review.","volume":"14","author":"V\u00e1rb\u00edr\u00f3","year":"2022","journal-title":"Nutrients"},{"key":"R9-20260218","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.3390\/ijms25126330","article-title":"A cross-sectional exploratory study of cardiovascular risk biomarkers in non-obese women with and without polycystic ovary syndrome: association with vitamin D.","volume":"25","author":"Nandakumar","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R10-20260218","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fendo.2020.00171","article-title":"Vitamin D deficiency is associated with metabolic risk factors in women with polycystic ovary syndrome: a cross-sectional study in Shaanxi China.","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol"},{"key":"R11-20260218","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12920-023-01541-8","article-title":"Vitamin D receptor gene polymorphism and polycystic ovary syndrome susceptibility.","volume":"16","author":"Albahlol","year":"2023","journal-title":"BMC Med Genomics"},{"key":"R12-20260218","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.4314\/ahs.v20i4.45","article-title":"The relationship between Vitamin D deficiency and polycystic ovary syndrome.","volume":"20","author":"Gokosmanoglu","year":"2020","journal-title":"Afr Health Sci"},{"key":"R13-20260218","doi-asserted-by":"crossref","first-page":"103633","DOI":"10.1016\/j.jri.2022.103633","article-title":"Vitamin D deficiency and female infertility: a mechanism review examining the role of vitamin D in ovulatory dysfunction as a symptom of polycystic ovary syndrome.","volume":"151","author":"Berry","year":"2022","journal-title":"J Reprod Immunol"},{"key":"R14-20260218","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.3390\/nu11112831","article-title":"Vitamin D levels in women with polycystic ovary syndrome: a population-based study.","volume":"11","author":"Lumme","year":"2019","journal-title":"Nutrients"},{"key":"R15-20260218","article-title":"Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome.","volume":"31","author":"Ng","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"R16-20260218","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R17-20260218","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11154-017-9424-1","article-title":"The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention.","volume":"18","author":"Holick","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"R18-20260218","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13643-016-0259-8","article-title":"Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews.","volume":"5","author":"J\u00f8rgensen","year":"2016","journal-title":"Syst Rev"},{"key":"R19-20260218","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range.","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"R20-20260218","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-0716-1566-9_3","article-title":"Fixed- and random-effects models.","volume":"2345","author":"Kanters","year":"2022","journal-title":"Methods Mol Biol"},{"key":"R21-20260218","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/nu13020547","article-title":"Effects of vitamin D supplementation on surrogate markers of fertility in PCOS women: a randomized controlled trial.","volume":"13","author":"Lerchbaum","year":"2021","journal-title":"Nutrients"},{"key":"R22-20260218","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.clnu.2020.09.024","article-title":"Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: a randomized placebo controlled clinical trial.","volume":"40","author":"Al-Bayyari","year":"2021","journal-title":"Clin Nutr"},{"key":"R23-20260218","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/nu11010188","article-title":"A randomized, controlled trial of vitamin D supplementation on cardiovascular risk factors, hormones, and liver markers in women with polycystic ovary syndrome.","volume":"11","author":"Javed","year":"2019","journal-title":"Nutrients"},{"key":"R24-20260218","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12958-018-0413-3","article-title":"The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.","volume":"16","author":"Dastorani","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"R25-20260218","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40618-017-0785-9","article-title":"The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.","volume":"41","author":"Jafari-Sfidvajani","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"R26-20260218","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0043-107242","article-title":"The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.","volume":"49","author":"Maktabi","year":"2017","journal-title":"Horm Metab Res"},{"key":"R27-20260218","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/09513590.2017.1418311","article-title":"The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.","volume":"34","author":"Seyyed Abootorabi","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"R28-20260218","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/nu9121280","article-title":"Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome.","volume":"9","author":"Jamilian","year":"2017","journal-title":"Nutrients"},{"key":"R29-20260218","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1210\/jc.2015-2580","article-title":"Vitamin D supplementation decreases TGF-\u03b21 bioavailability in PCOS: a randomized placebo-controlled trial.","volume":"100","author":"Irani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20260218","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.fertnstert.2014.02.021","article-title":"High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.","volume":"101","author":"Raja-Khan","year":"2014","journal-title":"Fertil Steril"},{"key":"R31-20260218","doi-asserted-by":"crossref","first-page":"e0178120","DOI":"10.1371\/journal.pone.0178120","article-title":"Insulin resistance according to \u03b2-cell function in women with polycystic ovary syndrome and normal glucose tolerance.","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"key":"R32-20260218","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/09513590.2014.910189","article-title":"25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.","volume":"30","author":"G\u00fcd\u00fcc\u00fc","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R33-20260218","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.3390\/jcm11154509","article-title":"PCOS physiopathology and vitamin D deficiency: biological insights and perspectives for treatment.","volume":"11","author":"Morgante","year":"2022","journal-title":"J Clin Med"},{"key":"R34-20260218","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.3390\/nu13103491","article-title":"Mechanisms involved in the relationship between vitamin D and insulin resistance: impact on clinical practice.","volume":"13","author":"Contreras-Bol\u00edvar","year":"2021","journal-title":"Nutrients"},{"key":"R35-20260218","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4274\/tjod.galenos.2019.46244","article-title":"Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome.","volume":"16","author":"Behmanesh","year":"2019","journal-title":"Turk J Obstet Gynecol"},{"key":"R36-20260218","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/nu10111637","article-title":"The role of vitamin D oral supplementation in insulin resistance in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.","volume":"10","author":"\u0141agowska","year":"2018","journal-title":"Nutrients"},{"key":"R37-20260218","first-page":"BC01","article-title":"Hypovitaminosis D and associated cardiometabolic risk in women with PCOS.","volume":"10","author":"Mishra","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R38-20260218","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1210\/jc.2015-4352","article-title":"Vitamin D status relates to reproductive outcome in women with polycystic ovary syndrome: secondary analysis of a multicenter randomized controlled trial.","volume":"101","author":"Pal","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-20260218","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mnfr.201500259","article-title":"Vitamin D in polycystic ovary syndrome: relationship to obesity and insulin resistance.","volume":"60","author":"Joham","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"R40-20260218","first-page":"235","article-title":"The effect of vitamin D supplementation on insulin resistance among women with polycystic ovary syndrome.","volume":"23","author":"Salehpour","year":"2019","journal-title":"JBRA Assist Reprod"},{"key":"R41-20260218","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome.","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-20260218","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2017.05.014","article-title":"The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.","volume":"214","author":"Tola","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R43-20260218","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09513590.2014.976546","article-title":"The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.","volume":"31","author":"Souza Dos Santos","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"R44-20260218","doi-asserted-by":"crossref","first-page":"4092470","DOI":"10.1155\/2020\/4092470","article-title":"Inflammatory markers in women with polycystic ovary syndrome.","volume":"2020","author":"Rudnicka","year":"2020","journal-title":"Biomed Res Int"},{"key":"R45-20260218","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"R46-20260218","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1515\/hsz-2015-0149","article-title":"C-reactive protein and inflammation: conformational changes affect function.","volume":"396","author":"Wu","year":"2015","journal-title":"Biol Chem"},{"key":"R47-20260218","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.amjmed.2009.09.024","article-title":"Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations?","volume":"123","author":"Ngo","year":"2010","journal-title":"Am J Med"},{"key":"R48-20260218","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2015.03.011","article-title":"Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: vitamin D3 megadose reduces inflammatory markers.","volume":"66","author":"de Medeiros Cavalcante","year":"2015","journal-title":"Exp Gerontol"},{"key":"R49-20260218","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2567.2003.01608.x","article-title":"Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C\/EBPbeta and signal transducer and activator of transcription-3.","volume":"108","author":"Agrawal","year":"2003","journal-title":"Immunology"},{"key":"R50-20260218","doi-asserted-by":"crossref","first-page":"108570","DOI":"10.1016\/j.steroids.2019.108570","article-title":"25-Hydroxyvitamin D(3) positively regulates periodontal inflammaging via SOCS3\/STAT signaling in diabetic mice.","volume":"156","author":"Wang","year":"2020","journal-title":"Steroids"},{"key":"R51-20260218","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0043-125148","article-title":"The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.","volume":"50","author":"Akbari","year":"2018","journal-title":"Horm Metab Res"},{"key":"R52-20260218","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13048-019-0480-x","article-title":"Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.","volume":"12","author":"Ostadmohammadi","year":"2019","journal-title":"J Ovarian Res"},{"key":"R53-20260218","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"key":"R54-20260218","doi-asserted-by":"crossref","first-page":"894935","DOI":"10.3389\/fendo.2022.894935","article-title":"Low serum 25-hydroxyvitamin D levels are associated with hyperandrogenemia in polycystic ovary syndrome: a cross-sectional study.","volume":"13","author":"Shan","year":"2022","journal-title":"Front Endocrinol"},{"key":"R55-20260218","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/09513590.2020.1810228","article-title":"The correlation between vitamin D, glucose homeostasis and androgen level among polycystic ovary syndrome patients: a cross-sectional study.","volume":"37","author":"Li","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"R56-20260218","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0043-103573","article-title":"The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials.","volume":"49","author":"Azadi-Yazdi","year":"2017","journal-title":"Horm Metab Res"},{"key":"R57-20260218","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jog.13516","article-title":"Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.","volume":"44","author":"Karada\u011f","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"R58-20260218","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/nu12051219","article-title":"The relationship between vitamin D metabolites and androgens in women with polycystic ovary syndrome.","volume":"12","author":"Mesinovic","year":"2020","journal-title":"Nutrients"},{"key":"R59-20260218","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12944-020-01410-8","article-title":"Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.","volume":"19","author":"Kheirollahi","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R60-20260218","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.","volume":"172","author":"Glintborg","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R61-20260218","doi-asserted-by":"crossref","first-page":"8849688","DOI":"10.1155\/2021\/8849688","article-title":"The effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.","volume":"2021","author":"Gao","year":"2021","journal-title":"Int J Endocrinol"},{"key":"R62-20260218","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/nutrit\/nuz037","article-title":"Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis.","volume":"77","author":"Dibaba","year":"2019","journal-title":"Nutr Rev"},{"key":"R63-20260218","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clnu.2014.09.015","article-title":"Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.","volume":"34","author":"Asemi","year":"2015","journal-title":"Clin Nutr"},{"key":"R64-20260218","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0043-104530","article-title":"The effects of calcium, vitamins D and K co-supplementation on markers of insulin metabolism and lipid profiles in vitamin D-deficient women with polycystic ovary syndrome.","volume":"125","author":"Karamali","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R65-20260218","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.numecd.2022.03.018","article-title":"Dietary calcium intake in relation to blood lipids and lipoproteins profiles: a systematic review and meta-analysis of epidemiologic studies.","volume":"32","author":"Hajhashemy","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R66-20260218","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1248\/bpb.28.1418","article-title":"The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes.","volume":"28","author":"Cho","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"R67-20260218","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu10040482","article-title":"The when, what & how of measuring vitamin D metabolism in clinical medicine.","volume":"10","author":"Dirks","year":"2018","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:25:02Z","timestamp":1786040702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046892","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"2025-03-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}